… Kovesdy, MD, Vivian Kurtz, MPH, Danielle Lavallee, PharmD, PhD, Yi Li, PhD, Yee Lu,
MD, Keith McCullough, MS, Miklos Z. Molnar, MD, PhD, Maria Montez-Rath, PhD, Hal …

Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …

Background Data for trends in glycaemia and diabetes prevalence are needed to understand
the effects of diet and lifestyle within populations, assess the performance of interventions, …

This article presents an overview of current research activities that center on monodispersed
colloidal spheres whose diameter falls anywhere in the range of 10 nm to 1 μm. It is …

Objective To investigate the relationship between job satisfaction, work stress, work–family
conflict and turnover intention, and explore factors associated with turnover intention, among …

Objective To better inform efforts to treat and control the current outbreak with a comprehensive
characterization of COVID-19. Methods We searched PubMed, EMBASE, Web of Science…

Topic To provide updated estimates on the global prevalence and number of people with
diabetic retinopathy (DR) through 2045. Clinical Relevance The International Diabetes …

Background In 2010, overweight and obesity were estimated to cause 3·4 million deaths, 3·9%
of years of life lost, and 3·8% of disability-adjusted life-years (DALYs) worldwide. The rise …

Background There is a rapidly increasing amount of de novo genome assembly using next-generation
sequencing (NGS) short reads; however, several big challenges remain to be …

Background Quantification of the disease burden caused by different risks informs
prevention by providing an account of health loss different to that provided by a disease-by-disease …